These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35565169)

  • 41. Measured and self-reported olfactory function in voluntary Norwegian adults.
    Heian IT; Helvik AS; Hummel T; Øie MR; Nordgård S; Bratt M; Thorstensen WM
    Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4925-4933. PubMed ID: 35195760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Olfactory Cleft Width and Volumes in Patients with COVID-19 Anosmia and COVID-19 Cases Without Anosmia.
    Tekcan Sanli DE; Altundag A; Yıldırım D; Kandemirli SG; Sanli AN
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(1):1-9. PubMed ID: 34569549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Hedonics and Magnitude Upon Validated Psychophysical Olfactory Tests and Olfactory-Specific Quality of Life.
    Shih MC; Soler ZM; Germroth M; Snyder J; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2023 May; 37(3):253-263. PubMed ID: 36341557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of odor identification function in Asia using a modified "Sniffin' Stick" odor identification test.
    Shu CH; Yuan BC
    Eur Arch Otorhinolaryngol; 2008 Jul; 265(7):787-90. PubMed ID: 18064480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan.
    Cheng MY; Hsih WH; Ho MW; Lai YC; Liao WC; Chen CY; Chen TC; Lee YL; Liu PY; Kao CC; Chou CH; Lin PC; Chi CY; Leong LY; Tai CJ; Lu MC
    J Microbiol Immunol Infect; 2021 Oct; 54(5):794-800. PubMed ID: 33610511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up.
    Vaira LA; Salzano G; Le Bon SD; Maglio A; Petrocelli M; Steffens Y; Ligas E; Maglitto F; Lechien JR; Saussez S; Vatrella A; Salzano FA; Boscolo-Rizzo P; Hopkins C; De Riu G
    Otolaryngol Head Neck Surg; 2022 Jul; 167(1):183-186. PubMed ID: 34813382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
    Lechner M; Chandrasekharan D; Jumani K; Liu J; Gane S; Lund VJ; Philpott C; Jayaraj S
    Rhinology; 2020 Aug; 58(4):394-399. PubMed ID: 32386285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of olfactory and gustatory functions in COVID-19 patients.
    Şahin MM; Uzunoğlu E; Yalçın M; Cesur G; Yıldız M; Aysert Yıldız P; Özger HS; Cebeci S; Karamert R; Düzlü M; Tutar H; Dizbay M; Ceylan A
    Turk J Med Sci; 2021 Oct; 51(5):2296-2303. PubMed ID: 34333903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study.
    Miyake MM; Valera FCP; Martins RB; Compagnoni IM; Fantucci MZ; Murashima AAB; da Silva LECM; de Lima TM; de Souza MVO; Melo SR; Dolci RLL; Floriano CG; de Campos CAC; Nakanishi M; Freire GSM; Valente AL; Fornazieri MA; da Silva JLB; Anzolin LK; Issa MJA; Souza TV; Lima BA; SantAnna GD; Abreu CB; Sakano E; Cassettari AJ; Avelino MAG; Goncalves MC; de Camargo LA; Romano FR; Alves RD; Roithmann R; Redeker NK; Filho LLB; Dassi CS; Meurer ATO; Garcia DM; Aragon DC; Tepedino MS; Succar ACS; Vianna PM; Dos Santos MCJ; Filho RHR; Kosugi EM; Villa JF; Gregorio LL; Piltcher OB; Meotti CD; Tamashiro E; Arruda E; Anselmo Lima WT
    Rhinology; 2024 Feb; 62(1):55-62. PubMed ID: 37772802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced olfactory bulb volume accompanies olfactory dysfunction after mild SARS-CoV-2 infection.
    Petersen M; Becker B; Schell M; Mayer C; Naegele FL; Petersen E; Twerenbold R; Thomalla G; Cheng B; Betz C; Hoffmann AS
    Sci Rep; 2024 Jun; 14(1):13396. PubMed ID: 38862636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoantibody profiles assessment in individuals with persistent olfactory impairment following SARS-CoV-2 infection.
    Fiorelli D; Francavilla B; Velletrani G; Maurantonio S; Passali FM; Bernardini S; Di Girolamo S; Nuccetelli M
    Int Immunopharmacol; 2024 Mar; 129():111599. PubMed ID: 38330796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The "Sniffin' Kids" test--a 14-item odor identification test for children.
    Schriever VA; Mori E; Petters W; Boerner C; Smitka M; Hummel T
    PLoS One; 2014; 9(6):e101086. PubMed ID: 24979650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Remote psychophysical testing of smell in patients with persistent olfactory dysfunction after COVID-19.
    Martončíková M; Doležal P; Fabianová K; Karhánek M; Gálik J; Raček A; Popovičová A; Račeková E
    Sci Rep; 2023 Aug; 13(1):14090. PubMed ID: 37640847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-6 affects the severity of olfactory disorder: a cross-sectional survey of 148 patients who recovered from Omicron infection using the Sniffin' Sticks test in Tianjin, China.
    Liang Y; Mao X; Kuang M; Zhi J; Zhang Z; Bo M; Zhang G; Lin P; Wang W; Shen Z
    Int J Infect Dis; 2022 Oct; 123():17-24. PubMed ID: 35931372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Danish validation of sniffin' sticks olfactory test for threshold, discrimination, and identification.
    Niklassen AS; Ovesen T; Fernandes H; Fjaeldstad AW
    Laryngoscope; 2018 Aug; 128(8):1759-1766. PubMed ID: 29266246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical, Prognostic, and Predictive Value of Olfactory Dysfunction for COVID-19: A Prospective Controlled Study.
    Kavaz E; Tahir E; Kurnaz SÇ; Deveci A; Tanyel EA
    Otolaryngol Head Neck Surg; 2022 Jul; 167(1):187-196. PubMed ID: 34726987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of the Sniffin' Sticks olfactory test in Taiwan and comparison with different continents.
    Yuan BC; Lee PL; Lee YL; Lin SH; Shu CH
    J Chin Med Assoc; 2010 Sep; 73(9):483-6. PubMed ID: 20875622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction.
    Mendes Paranhos AC; Nazareth Dias ÁR; Machado da Silva LC; Vieira Hennemann Koury G; de Jesus Sousa E; Cerasi AJ; Souza GS; Simões Quaresma JA; Magno Falcão LF
    JAMA Netw Open; 2022 Sep; 5(9):e2230637. PubMed ID: 36074464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation study of the "Sniffin' Sticks" olfactory test in a British population: a preliminary communication.
    Neumann C; Tsioulos K; Merkonidis C; Salam M; Clark A; Philpott C
    Clin Otolaryngol; 2012 Feb; 37(1):23-7. PubMed ID: 22433135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.
    Shrestha I; Mishra A; Mishra A; Bista M; Acharya J
    Kathmandu Univ Med J (KUMJ); 2021; 19(74):173-179. PubMed ID: 34819431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.